A major move is in the offing as SpringWorks Therapeutics Inc (SWTX) market cap hits 3.17 billion

SQ

On Tuesday, SpringWorks Therapeutics Inc (NASDAQ: SWTX) opened higher 1.62% from the last session, before settling in for the closing price of $41.87. Price fluctuations for SWTX have ranged from $28.21 to $53.92 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -20.00%. Company’s average yearly earnings per share was noted 39.79% at the time writing. With a float of $65.79 million, this company’s outstanding shares have now reached $74.34 million.

Considering the fact that the conglomerate employs 305 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 93.59%, operating margin of -217.92%, and the pretax margin is -203.09%.

SpringWorks Therapeutics Inc (SWTX) Insider Activity

A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of SpringWorks Therapeutics Inc is 11.56%, while institutional ownership is 101.86%. The most recent insider transaction that took place on Sep 03 ’24, was worth 1,988,033. In this transaction Chief Executive Officer of this company sold 49,000 shares at a rate of $40.57, taking the stock ownership to the 1,063,368 shares. Before that another transaction happened on Sep 03 ’24, when Company’s Chief Operating Officer sold 20,000 for $40.65, making the entire transaction worth $812,954. This insider now owns 229,600 shares in total.

SpringWorks Therapeutics Inc (SWTX) Earnings and Forecasts

According to the Wall Street analysts, stocks earnings will be around 39.79% per share during the next fiscal year.

SpringWorks Therapeutics Inc (NASDAQ: SWTX) Trading Performance Indicators

Check out the current performance indicators for SpringWorks Therapeutics Inc (SWTX). In the past quarter, the stock posted a quick ratio of 6.02. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 23.36.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.73, a number that is poised to hit -0.65 in the next quarter and is forecasted to reach -2.01 in one year’s time.

Technical Analysis of SpringWorks Therapeutics Inc (SWTX)

Compared to the last year’s volume of 1.0 million, its volume of 0.86 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 93.83%. Additionally, its Average True Range was 1.88.

During the past 100 days, SpringWorks Therapeutics Inc’s (SWTX) raw stochastic average was set at 92.94%, which indicates a significant decrease from 99.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.34% in the past 14 days, which was higher than the 47.20% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $33.39, while its 200-day Moving Average is $39.75. Nevertheless, the first resistance level for the watch stands at $43.09 in the near term. At $43.64, the stock is likely to face the second major resistance level. The third major resistance level sits at $44.65. If the price goes on to break the first support level at $41.53, it is likely to go to the next support level at $40.52. Should the price break the second support level, the third support level stands at $39.97.

SpringWorks Therapeutics Inc (NASDAQ: SWTX) Key Stats

There are currently 74,386K shares outstanding in the company with a market cap of 3.17 billion. Presently, the company’s annual sales total 5,450 K according to its annual income of -325,100 K. Last quarter, the company’s sales amounted to 49,300 K and its income totaled -53,530 K.